[1] |
World Health Organization. Global tuberculosis report 2021. Geneva: World Health Organization,2021.
|
[2] |
Getahun H, Matteelli A, Chaisson Re, et al. Latent Mycobacterium tuberculosis infection. N Engl J Med, 2015, 372(22): 2127-2135. doi: 10.1056/NEJMra1405427.
doi: 10.1056/NEJMra1405427
URL
|
[3] |
Petrucci R, Lombardi G, Corsini I, et al. Quantiferon-Tb Gold In-Tube Improves Tuberculosis Diagnosis In Children. Pediatr Infect Dis J, 2017, 36(1): 44-49. doi: 10.1097/Inf.0000000000001350.
doi: 10.1097/Inf.0000000000001350
pmid: 27749653
|
[4] |
Sester M, Sotgiu G, Lange C, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2011, 37(1): 100-111. doi: 10.1183/09031936.00114810.
doi: 10.1183/09031936.00114810
pmid: 20847080
|
[5] |
Laurenti P, Raponi M, de Waure C, et al. Performance of interferon-γ release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis. BMC Infect Dis, 2016, 16:131. doi: 10.1186/s12879-016-1461-y.
doi: 10.1186/s12879-016-1461-y
URL
|
[6] |
Farhat M, Greenaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis, 2006, 10(11): 1192-1204.
|
[7] |
Shetty N, Shemko M, Vaz M, et al. An epidemiological evalua-tion of risk factors for tuberculosis in South India: a matched case control study. Int J Tuberc Lung Dis, 2006, 10(1): 80-86.
pmid: 16466042
|
[8] |
Cegielski JP, Mcmurray DN. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis, 2004, 8(3): 286-298.
pmid: 15139466
|
[9] |
Thomas TA, Mondal D, Noor Z, et al. Malnutrition and helminth infection affect performance of an interferon gamma-release assay. Pediatrics, 2010, 126(6): e1522-9. doi: 10.1542/peds.2010-0885.
doi: 10.1542/peds.2010-0885
URL
|
[10] |
Anuradha R, Munisankar S, Bhootra Y et al. Malnutrition is associated with diminished baseline and mycobacterial antigen-stimulated chemokine responses in latent tuberculosis infection. J Infect, 2018, 77(5): 410-416. doi: 10.1016/j.jinf.2018.05.003.
doi: 10.1016/j.jinf.2018.05.003
URL
|
[11] |
Boddu D, Verghese Vp, Michael Js, et al. Utility of Quanti-FERON-TB gold In-Tube test compared with tuberculin skin test in diagnosing tuberculosis in Indian children with malnutrition. Indian J Med Microbiol, 2019, 37(3): 433-437. doi: 10.4103/ijmm.IJMM_19_227.
doi: 10.4103/ijmm.IJMM_19_227
URL
|
[12] |
Pan L, Jia H, Liu F et al. Risk factors for false-negative T-SPOT.TB assay results in patients with pulmonary and extra-pulmonary TB. J Infect, 2015, 70(4): 367-380. doi: 10.1016/j.jinf.2014.12.018.
doi: 10.1016/j.jinf.2014.12.018
URL
|
[13] |
Flynn JL, Chan J. Immunology of tuberculosi. Annu Rev Immunol, 2001, 19:93-129. doi: 10.1146/annurev.immunol.19.1.93.
doi: 10.1146/annurev.immunol.19.1.93
pmid: 11244032
|
[14] |
Leung WL, Law KL, Leung VS, et al. Comparison of intracellular cytokine flow cytometry and an enzyme immunoassay for evaluation of cellular immune response to active tuberculosis. Clin Vaccine Immunol, 2009, 16(3): 344-351. doi: 10.1128/CVI.00159-08.
doi: 10.1128/CVI.00159-08
pmid: 19129466
|
[15] |
Yamasue M, Komiya K, Usagawa Y, et al. Factors associated with false negative interferon-γ release assay results in patients with tuberculosis:A systematic review with meta-analysis. Sci Rep, 2020, 10(1): 1607. doi: 10.1038/s41598-020-58459-9.
doi: 10.1038/s41598-020-58459-9
pmid: 32005930
|
[16] |
Xu N, Tu W, Jin T, et al. Clinical application, evaluation and analysis of influencing factors of on tuberculosis γ-Interferon enzyme-linked immunosorbent assay. J Pak Med Assoc, 2021, 71(11): 2543-2547. doi: 10.47391/JPMA.1036.
doi: 10.47391/JPMA.1036
URL
|
[17] |
Igari H, Ishikawa S, Nakazawa T, et al. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis. J Infect Chemother, 2018, 24(2): 110-116. doi: 0.1016/j.jiac.2017.09.012.
doi: 0.1016/j.jiac.2017.09.012
URL
|
[18] |
Procaccini C, De Rosa V, Galgani M, et al. Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J Immunol, 2012, 189(6): 2941-2953. doi: 10.4049/jimmunol.1200935.
doi: 10.4049/jimmunol.1200935
pmid: 22904304
|
[19] |
Nájera O, González C, Toledo G, et al. Flow cytometry study of lymphocyte subsets in malnourished and well-nourished children with bacterial infections. Clin Diagn Lab Immunol, 2004, 11(3): 577-580. doi: 10.1128/CDLI.11.3.577-580.2004.
doi: 10.1128/CDLI.11.3.577-580.2004
|
[20] |
Walsh MC, Camerlin AJ, Miles R, et al. The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes. Int J Tuberc Lung Dis, 2011, 15(2): 179-184, i-iii.
pmid: 21219678
|
[21] |
Chee CB, Gan SH, Khinmar KW, et al. Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol, 2008, 46(6): 1935-1940. doi: 10.1128/JCM.02403-07.
doi: 10.1128/JCM.02403-07
URL
|
[22] |
Kobashi Y, Mouri K, Obase Y, et al. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J, 2007, 30(5): 945-950. doi: 10.1183/09031936.00040007.
doi: 10.1183/09031936.00040007
pmid: 17652312
|
[23] |
Park Sy, Jeon K, Um SW, et al. Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis. Scand J Infect Dis, 2009, 41(11-12): 818-822. doi: 10.3109/00365540903214298.
doi: 10.3109/00365540903214298
URL
|